跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 8,503 条关于
“Escherichia coli Nissle 1917”
全部
8,503
临床试验
7,740
药物
376
机构
26
资讯
361
18天前
Engineered Probiotic Carriers Emerge as Living Drug Factories for Tumor-Targeted Therapy
去年
Synlogic's Novel Probiotic Therapy Shows Promise in Phase 2 PKU Trial, Advancing to Phase 3
去年
IIT Roorkee Researchers Uncover Novel Mechanism of Antibiotic Resistance in E. coli
去年
CARB-X Awards $2 Million to Immunethep for Novel E. coli Vaccine Development
去年
Sanofi and J&J Join Forces in $175M Deal to Combat E. coli Sepsis with Novel Vaccine
去年
SiVEC's BactPac Platform: Engineered Bacteria Redefining Targeted Drug Delivery for Cancer and Beyond
6个月前
ETVAX Oral Vaccine Shows Promise Against Deadly E. Coli Infections in Children
去年
SNIPR Biome Doses First Patient with CRISPR-Armed Phage Therapy SNIPR001 for Drug-Resistant E. coli Prevention
去年
Australian Researchers Develop AI-Designed Protein to Combat Antibiotic-Resistant E. Coli
去年
CARB-X Awards $1.1 Million to Phiogen for Novel Bacteriophage Treatment Against Drug-Resistant E. coli Bloodstream Infections
第 1 页，共 37 页
上一页
下一页
